BIOLIDICS LIMITED
(SGX: 8YY)

The Company is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company aspires to impact the lives of patients through the provision of diagnostic solutions in every cancer centre worldwide.The Company has developed the ClearCell FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patients body.

0.022 -

- (-%)
Range 0.022 - 0.022   (-%)
Open 0.022
Previous Close 0.022
Bid Price 0.022
Bid Volume ('000) 2.2
Ask Price 0.023
Ask Volume ('000) 946.9
Volume ('000) 218.4
Value 4,805
Remark -
Delayed prices. Updated at 17 Jun 2025 10:44.
Data powered by

Upcoming Events

EGM

Meeting Date 17 June 2025
Meeting Time 10:30 AM
10.30 A.M. AT 18 HOWARD ROAD, #02-07 NOVELTY BIZCENTRE, SINGAPORE 369585.
Data powered by SGX.
View All Events


Loading Chart...

Please login to view stock data and analysis